Traditional Chinese medicine composition for treating kidney deficiency type ovarian reserve function decline disease and application thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
An ovarian reserve and composition technology, which is applied in the field of traditional Chinese medicine compositions for the treatment of kidney deficiency type ovarian reserve dysfunction diseases, can solve the problems of small side effects and significant curative effect, and achieves improvement of traditional Chinese medicine syndrome, increase of antral follicle count, and good clinical curative effect. Effect
Inactive Publication Date: 2022-04-19
上海市静安区中医医院
View PDF2 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0006] And at present about curative effect is remarkable, and side effect is little, and a kind of Chinese medicine composition for the treatment of kidney-deficiency type ovarian reserve function decline disease of rapid onset has not been reported yet.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0017] Embodiment 1 Chinese medicine composition of the present invention (1)
[0018] Take each raw material medicine by weight ratio: 12 parts of Poria cocos, 10 parts of raw land, 10 parts of Rehmannia glutinosa, 10 parts of Ligustrum lucidum, 10 parts of curculigo, 10 parts of fairy spleen, 10 parts of Morinda officinalis, 10 parts of Cistanche, 10 parts of antler cream, 30 parts of amethyst.
Embodiment 2
[0019] Embodiment 2 Chinese medicine composition of the present invention (two)
[0020] Weigh each raw material according to the weight ratio: 12 parts of Poria cocos, 8 parts of rehmannia, 12 parts of Rehmannia glutinosa, 10 parts of Ligustrum lucidum, 8 parts of curculigo, 12 parts of fairy spleen, 9 parts of Morinda officinalis, 11 parts of Cistanche, 12 parts of antler cream, 29 parts of amethyst.
Embodiment 3
[0021] Embodiment 3 Chinese medicine composition of the present invention (three)
[0022] Weigh each raw material medicine according to weight ratio: 10 parts of Poria cocos, 12 parts of rehmannia glutinosa, 9 parts of Rehmannia glutinosa, 8 parts of Ligustrum lucidum, 12 parts of curculigo, 9 parts of fairy spleen, 11 parts of Morinda officinalis, 10 parts of Cistanche, 9 parts of antler cream, 31 parts of amethyst.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a traditional Chinese medicine composition for treating kidney deficiency type ovarian reserve function decline diseases. The traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 10-14 parts of poria cocos, 8-12 parts of radix rehmanniae, 8-12 parts of radix rehmanniae preparata, 8-12 parts of glossy privet fruits, 8-12 parts of rhizoma curculiginis, 8-12 parts of herba epimedii, 8-12 parts of radix morindae officinalis, 8-12 parts of herba cistanche, 8-12 parts of cornu cervi degelatinatum and 28-32 parts of amethyst. The invention further provides application of the traditional Chinese medicine composition. The traditional Chinese medicine composition can effectively improve the endocrine hormone level of a DOR patient, improve the menstruation condition and relieve clinical symptoms, has a good clinical curative effect, is an effective proved recipe for treating the DOR, provides a thought and evidence-based medical evidence for treating the DOR through traditional Chinese medicine, and is worthy of further defining the action mechanism of the traditional Chinese medicine composition for improving the ovarian reserve function subsequently.
Description
technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating kidney-deficiency type ovarian reserve function decline and its application. Background technique [0002] The etiology and pathogenesis of decreased ovarian reserve (DOR) are complex. With the increase of social pressure on women, the intensification of environmental pollution, and unhealthy living habits, the incidence of DOR is increasing year by year and showing a trend of younger age. At present, Western medicine mainly focuses on hormone replacement in treatment. Scholars at home and abroad believe that the application of HRT in patients with ovarian function decline can give HPOA a temporary rest and temporarily control the disease. Studies have shown that FSH can be significantly reduced after 3 months of treatment. However, although femotone can reduce the level of FSH, FSH may rebound after...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more